Article
Viral escape mutations do not account for non-protection from SIVmac239 challenge in RhCMV/SIV vaccinated rhesus macaques.
Frontiers in immunology - 1 Jan 2024
Bimber Benjamin N, Sunshine Justine, McElfresh G W, Reed Jason S, Pathak Reese, Bateman Katherine B, Hughes Colette M, Gilbride Roxanne M, Ford Julia C, Morrow David, Lifson Jeffrey D, Sacha Jonah B, Hansen Scott G, Picker Louis J
Abstract excerpt
Simian immunodeficiency virus (SIV) vaccines based upon 68-1 Rhesus Cytomegalovirus (RhCMV) vectors show remarkable protection against pathogenic SIVmac239 challenge. Across multiple independent rhesus macaque (RM) challenge studies, nearly 60% of vaccinated RM show early, complete arrest of SIVmac239 replication after effective challenge, whereas the remainder show progressive infection similar to controls....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
